Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Sandra, Eloranta"'
Autor:
Joachim Baech, Tarec Christoffer El‐Galaly, Joshua P. Entrop, Ingrid Glimelius, Daniel Molin, Sissel Johanne Godtfredsen, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Dietrich
Publikováno v:
eJHaem, Vol 5, Iss 6, Pp 1190-1200 (2024)
Abstract Introduction Congestive heart failure (CHF) is a known complication after anthracyclines and radiotherapy for classical Hodgkin lymphoma (cHL). Contemporary cHL treatment may be associated with less risk because radiotherapy use and techniqu
Externí odkaz:
https://doaj.org/article/1b7c3bb6089246c9a932aea190c17a9e
Publikováno v:
PeerJ, Vol 12, p e17841 (2024)
Background Optimising maintenance drug treatment selection for people with bipolar disorder is challenging. There is some evidence that clinical and demographic features may predict response to lithium. However, attempts to personalise treatment choi
Externí odkaz:
https://doaj.org/article/43cbb58a40ac472bb46d522a4501decb
Autor:
Henrik Benoni, Caroline Nordenvall, Vivan Hellström, Caroline E. Dietrich, Anna Martling, Karin E. Smedby, Sandra Eloranta
Publikováno v:
Transplant International, Vol 37 (2024)
Previous solid organ transplantation has been associated with worse survival among colorectal cancer (CRC) patients. This study investigates the contribution of CRC characteristics and treatment-related factors to the differential survival. Using the
Externí odkaz:
https://doaj.org/article/b415fc2be32149a0875a19489bc1ad6a
Autor:
Karin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, Victor Falini, Urban Jerlström, Fredrik Ellin, Karin Papworth, Johanna Westerberg, Catharina Lewerin, Per-Ola Andersson, Hallgerdur Lind Kristjansdottir, Lena Brandefors, Charlott Mörth, Karin Hallén, Nevzeta Kuric, Amal Abu Sabaa, Björn E. Wahlin, Daniel Molin, Gunilla Enblad, Ann-Sofi Hörstedt, Mats Jerkeman, Ingrid Glimelius
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The Swedish Lymphoma Register (SLR) was initiated in the year 2000 with the aim to monitor quality of care in diagnostics, treatment and outcome of all lymphomas diagnosed nationally among adults. Here, we present the first sy
Externí odkaz:
https://doaj.org/article/7ee070d713af42f29167468a2f959abb
Autor:
Kenny A Rodriguez-Wallberg, Jonas Bergh, Antonis Valachis, Per Frisk, Theodoros Foukakis, Per Ljungman, Sandra Eloranta, Hanna Pauline Nilsson, Johan Malmros, Christina Linder Stragliotto, Erika Isaksson Friman, Barbro Linderholm, Anne Andersson, Sara Harrysson, Lovisa Vennström, Helena Mörse
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Background Gonadotropin-releasing hormone agonists (GnRHa) cotreatment used to transiently suppress ovarian function during chemotherapy to prevent ovarian damage and preserve female fertility is used globally but efficacy is debated. Most clinical s
Externí odkaz:
https://doaj.org/article/ba5924fc50df467589005f382b3a4808
Autor:
Lasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, Joachim Bæch, Kristian Hay Kragholm, Ingrid Glimelius, Anne Ortved Gang, Judit Mészáros Jørgensen, Henrik Frederiksen, Christian Bjørn Poulsen, Michael Roost Clausen, Per Trøllund Pedersen, Robert Schou Pedersen, Christian Torp-Pedersen, Sandra Eloranta, Tarec Christoffer El-Galaly
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract For most patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), R-CHOP immunochemotherapy leads to complete remission and 60–70% of patients remain progression-free after 5 years. Given a median age of 65, it is relevant to d
Externí odkaz:
https://doaj.org/article/bb7dc74d74fd4d8696aca7534432f57e
Autor:
Núria Rodríguez Ruiz, Sulaf Abd Own, Karin Ekström Smedby, Sandra Eloranta, Sabine Koch, Tove Wästerlid, Aleksandra Krstic, Magnus Boman
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe increasing amount of molecular data and knowledge about genomic alterations from next-generation sequencing processes together allow for a greater understanding of individual patients, thereby advancing precision medicine. Molecular tum
Externí odkaz:
https://doaj.org/article/95dcbd805ef646bea270c89adfaf3940
Autor:
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Bjorn E. Wahlin, Per-Ola Andersson, Karin E. Smedby
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract We performed a national population-based study of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) in Sweden in 2007–2014 to assess treatment intent and risk of relapsed/refractory disease, including central nervous system
Externí odkaz:
https://doaj.org/article/a1305d2d921849bf9a6993bb265176df
Publikováno v:
BMJ Open Sport & Exercise Medicine, Vol 8, Iss 1 (2022)
Objectives Few studies have evaluated the prevalence of psychiatric disorders among treatment-seeking elite athletes (EA) or high-performance coaches (HPC) in psychiatric outpatient settings.Methods Descriptive overview of EA and HPC with psychiatric
Externí odkaz:
https://doaj.org/article/6c512ffaf9d34688a3a55a84d8b032e1
Autor:
Ingrid Glimelius, Annika Englund, Klaus Rostgaard, Karin E. Smedby, Sandra Eloranta, Peter de Nully Brown, Christoffer Johansen, Peter Kamper, Gustaf Ljungman, Lisa Lyngsie Hjalgrim, Henrik Hjalgrim
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4918-4927 (2019)
Abstract The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary protocols remains poorly characterized. We used nation‐wide registers to assess number of inpatient bed‐days and specialist outpatient vis
Externí odkaz:
https://doaj.org/article/7e419e6445ac48aa81302e10880da808